Becker, Kolja
Klein, Holger
Simon, Eric
Viollet, Coralie
Haslinger, Christian
Leparc, German
Schultheis, Christian
Chong, Victor
Kuehn, Markus H.
Fernandez-Albert, Francesc
Bakker, Remko A.
Funding for this research was provided by:
Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
Article History
Received: 22 January 2021
Accepted: 15 April 2021
First Online: 18 May 2021
Competing interests
: KB, HK, ES, CV, GL, CS, FFA, and RAB are employed by Boehringer Ingelheim Pharma GmbH & Co. KG. CH is employed by Boehringer Ingelheim RCV GmbH & Co KG. VC is employed by BI International GmbH. MHK has no conflict of interest.